Albumin is commonly used as a nutritional marker of protein-energy in clinical practice, however, we found prealbumin that responded quickly to nutritional interventions was more sensitive and suitable for NPC patients (46–48). The gene discussed is TTR; the disease is nasopharyngeal carcinoma.